Mission
We believe the most important tools for healthy aging are already inside us — in the gut ecosystem that shapes cognition, metabolic health, and women's health, with chronic inflammation as the common thread. Our work is to learn how to steer that ecosystem with precision, and to hand brands the actives to do it. Not louder supplements — better biology, made formulable.
What we do
Trilliome runs Teroka, a discovery engine that couples a wetlab data-generation loop with computational exploration to find precision bioactives — and their combinations — that modulate the gut ecosystem. Our first two actives, TRI-01 and TRI-04, are heading to market; more are in development. We're a healthcare company; our first products are precision bioactive ingredients, supplied B2B — no direct-to-consumer products, and no conflicts with the brands we serve. Explore the platform →
The insight
The industry usually hunts for benefits: start with a plant, screen for an effect, and hope it survives manufacturing. We started from the other end — from a conviction that the bacteria most tied to healthy aging are already in the gut, and that the real problem is activating them, not delivering them. That reframe is demanding: it needs human gut-model screening, species-level resolution, food-grade extraction, and an engine to do it repeatably. It took two scientists who'd spent 18+ years each at the seam of pharma, biotech, and nutrition to see what it required — and to build the company around it. The insight is why the platform exists; the team is why it works.
The founders
Patrick brings 18+ years of biopharma and biotech leadership across venture creation, operations, and fundraising — including roles as COO at Rejuveron, CSO at InSphero, Entrepreneur-in-Residence at General Inception, and Lab Head at Sanofi. MIT- and University of Basel-trained, he leads company strategy, fundraising, IP, and operations.
Tim brings 18+ years across pharma and nutrition, with deep microbiome science and B2B partnership experience (including dsm-firmenich, Janssen / J&J, and Redbiotec). Max Planck- and Cambridge-trained, with 19 publications, he leads the clinical program, commercial partnerships, regulatory strategy, and APAC expansion.
Advisory board
We're advised by senior leaders from leading global nutrition, pharma, and ingredient companies. (Individual advisors will be introduced here as each confirms.)
Traction
- 7 signed LOIs from supplement, functional-food, and ingredient partners — including a top-4 global ingredient company.
- Three industry awards in 2025 — EIT Food (1st), ARDD (2nd), and Probiota New Product of the Year.
- Selected by Venture Kick, EIT Food, and Innosuisse.
- A favourable EPO Search Opinion on the cognitive indication for our lead mechanism (see /ip).
Where we are
Switzerland-based, operating internationally. Incorporated 2023.
Partner with us → For investors → Subscribe →
FAQ
- What does Trilliome do? We're a Swiss healthcare company making precision bioactives — plant-derived actives that modulate the gut ecosystem for healthy aging — supplied to supplement and functional-food brands as B2B ingredients.
- Who founded it? Patrick Guye, PhD (CEO) and Tim Mak, PhD (CBO), two scientists with 18+ years each in biotech, pharma, and nutrition.
- Is it direct-to-consumer? No — pure-play B2B, so we never compete with the brands we supply.